Skip to main content
SpringerLink
Log in

Primary Sclerosing Cholangitis

  • Chapter
Clinical Hepatology

  • 1827 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Angulo P, Lindor KD (1999) Primary sclerosing cholangitis. Hepatology 30: 325–32

    Article  CAS  PubMed  Google Scholar 

  2. Angulo P, Peter JB, Gershwin ME, et al (2000) Serum autoan-tibodies in patients with primary sclerosing cholangitis. J Hepatol 32: 182–7

    Article  CAS  PubMed  Google Scholar 

  3. Angulo P, Maor-Kendler Y, Lindor KD (2002) Small-duct primary sclerosing cholangitis: a long-term follow-up study. Hepatology 35: 1494–500

    Article  PubMed  Google Scholar 

  4. Bambha K, Kim WR, Talwalkar J, et al (2003) Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a united states community. Gastroenteroogy 125: 1364–9

    Article  Google Scholar 

  5. Baron TH, Koehler RE, Rodgers WH, et al (1995) Mast cell cholangiopathy: another cause of sclerosing cholangitis. Gastroenterology 109: 1677–81

    Article  CAS  PubMed  Google Scholar 

  6. Bass NM, Chapman RW, O'Reilly A, et al (1983) Primary sclerosing cholangitis associated with angioimmunoblastic lymphadenopathy. Gastroenterology 85: 420–4

    Google Scholar 

  7. Bergquist A, Ekbom A, Olsson R, et al (2002) Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol 36: 321–7

    Article  PubMed  Google Scholar 

  8. Bergquist A, Lindberg G, Saarinen S, et al (2005) Increased prevalence of primary sclerosing cholangitis among first-degree relatives. J Hepatol 42: 252–6

    Article  PubMed  Google Scholar 

  9. Bergquist A, Glaumann H, Lindberg B, et al (2006) Primary sclerosing cholangitis can present with acute liver failure: report of two cases. J Hepatol 44: 1005–8

    Article  PubMed  Google Scholar 

  10. Björnsson E, Chiari ST, Smyrk TC, et al (2007) Immuno-globulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature. Hepatology 45: 1547–]54

    Article  PubMed  Google Scholar 

  11. Björnsson E, Olsson R, Bergquist A, et al (2008) The natural history of small-duct primary sclerosing cholangitis. Gastro-enterology 134: 975–80

    Article  Google Scholar 

  12. Boberg KM, Aadland E, Jahnsen J, et al (1998) Incidence and prevalence of primary biliary cirrhosis, primary scleros-ing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33: 99–103

    Article  CAS  PubMed  Google Scholar 

  13. Brandsaeter B, Isoniemi H, Broome U, et al (2004) Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy. J Hepatol 40: 815–22

    Article  CAS  PubMed  Google Scholar 

  14. Burak K, Angulo P, Pasha TM, et al (2004) Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol 99: 523–6

    Article  PubMed  Google Scholar 

  15. Card T, Solaymani-Dodaran M, West J (2008) Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol 48: 939–44

    Article  PubMed  Google Scholar 

  16. Charatcharoenwitthaya P, Angulo P, Enders FB, et al (2008) Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis. Hepatology 47: 133–42

    Article  CAS  PubMed  Google Scholar 

  17. Cullen SN, Rust C, Fleming K, et al (2008) High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective. J Hepatol 48: 792–800

    Article  CAS  PubMed  Google Scholar 

  18. Dienes HP, Lohse AW, Gerken G, et al (1997) Bile duct epi-thelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis. Virchows Arch 431: 119–24

    Article  CAS  PubMed  Google Scholar 

  19. Farkkila M, Karvonen AL, Nurmi H, et al (2004) Metron-idazole and ursodeoxycholic acid for primary sclerosing cho-langitis: a randomized placebo-controlled trial. Hepatology 40: 1379–86

    Article  PubMed  Google Scholar 

  20. Feldstein AE, Perrault J, El-Youssif M, et al (2003) Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology 38: 210–7

    Article  PubMed  Google Scholar 

  21. Gelbmann CM, Rümmele P, Wimmer M, et al (2007) Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients. Am J Gastroenterol 102: 1221–9

    Article  PubMed  Google Scholar 

  22. Ghazale A, Chari ST, Zhang L, et al (2008) Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 143: 706–15

    Google Scholar 

  23. Karlsen TH, Boberg KM, Olsson M, et al (2007) Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary scle-rosing cholangitis. J Hepatol 46: 899–906

    Article  CAS  PubMed  Google Scholar 

  24. Keaveny AP, Gordon FD, Goldar-NajafiA, et al (2004) Native liver xanthogranulomatous cholangiopathy in primary sclerosing cholangitis: impact on posttransplant outcome. Liver Transpl 10: 115–22

    Article  PubMed  Google Scholar 

  25. Khettry U, Keaveny A, Goldar-NajafiA, et al (2003) Liver transplantation for primary sclerosing cholangitis: a longterm clinicopathologic study. Hum Pathol 34: 1127–36

    Article  PubMed  Google Scholar 

  26. Kim WR, Ludwig J, Lindor KD (2000) Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol 95: 1130–8

    Article  CAS  PubMed  Google Scholar 

  27. Kulaksiz H, Rudolph G, Kloeters-Plachky P, et al (2006) Biliary candida infections in primary sclerosing cholangitis. J Hepatol 45: 711–6

    Article  PubMed  Google Scholar 

  28. Lindor KD (1997) Ursodiol for primary sclerosing cholangi-tis. N Engl J Med 336: 691–5

    Article  CAS  PubMed  Google Scholar 

  29. Ludwig J, Barham SS, LaRusso NF, et al (1981) Morphologic features of chronic hepatitis associated with primary scleros-ing cholangitis and chronic ulcerative colitis. Hepatology 1: 632–40

    Article  CAS  PubMed  Google Scholar 

  30. Ludwig J, MacCarty RL, LaRusso NF, et al (1986) Intrahepatic cholangiectases and large-duct obliteration in primary scle-rosing cholangitis. Hepatology 6: 560–8

    Article  CAS  PubMed  Google Scholar 

  31. Ludwig J (1991) Small-duct primary sclerosing cholangitis. Semin Liver Dis 11: 11–7

    Article  CAS  PubMed  Google Scholar 

  32. Maheshwari A, Yoo HY, Thuluvath PJ (2004) Long-term outcome of liver transplantation in patients with PSC: a comparative analysis with PBC. Am J Gastroenterol 99: 538–42

    Article  PubMed  Google Scholar 

  33. Mendes FD, Jorgensen R, Keach J, et al (2006) Elevated serum IgG4 concentration in patients with primary scleros-ing cholangitis. Am J Gastroenterol. 101: 2070–5

    Article  CAS  PubMed  Google Scholar 

  34. Mitchell SA, Bansi DS, Hunt N, et al (2001) A preliminary trial of high-dose ursodeoxycholic acid in primary scleros-ing cholangitis. Gastroenterology 121: 900–7

    Article  CAS  PubMed  Google Scholar 

  35. Okolicsanyi L, Groppo M, Floreani A, et al (2003) Treatment of primary sclerosing cholangitis with low-dose ursodeoxy-cholic acid: results of a retrospective Italian multicentre survey. Dig Liver Dis 35: 325–31

    Article  CAS  PubMed  Google Scholar 

  36. Olsson R, Boberg KM, Schaffalitsky de Muckadell O, et al (2005) High-dose ursodeoxycholic acid in primary scleros-ing cholangitis: a 5-year multicenter, randomized, controlled study. Gastroenterology 129: 1464–72

    Article  CAS  PubMed  Google Scholar 

  37. Ponsioen C Y, Tytgat GNJ (1998) Primary sclerosing cholan-gitis: a clinical review. Am J Gastroenterol 93: 515–23

    Article  CAS  PubMed  Google Scholar 

  38. Ponsioen CY, Vrouenraets SME, van Milligen de Wit AWM, et al (1999) Value of brush cytology for dominant strictures in primary sclerosing cholangitis. Endoscopy 31: 305–9

    Article  CAS  PubMed  Google Scholar 

  39. Prytz H, Keiding S, Björnsson E, et al (2006) Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation. Hepatology 44: 1572–80

    Article  CAS  PubMed  Google Scholar 

  40. Ramos FJ, Perez-Arellano JI, Lopez-Borrasca A (1987) Primary sclerosing cholangitis in histiocytosis X. Am J Med 82: 191

    Article  CAS  PubMed  Google Scholar 

  41. Rösch T, Dancygier H (1988) Primär sklerosierende Cho-langitis. Leber Magen Darm 18: 184–96

    PubMed  Google Scholar 

  42. Rost D, Rudolph G, Kloeters-Plachky P, et al (2004) Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 40: 693–8

    Article  CAS  PubMed  Google Scholar 

  43. Said K, Glaumann H, Bergquist A (2008) Gallbladder disease in patients with primary sclerosing cholangitis. J Hepatol 48: 598–605

    PubMed  Google Scholar 

  44. Stiehl A, Rudolph G, Sauer P, et al (1997) Efficacy of ursodeoxycholic acid treatment and endoscopic dilatation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study. J Hepatol 26: 560–6

    Article  CAS  PubMed  Google Scholar 

  45. Stiehl A, Rudolph G, Klöters-Plachky P, et al (2002) --Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. J Hepatol 36: 151–6

    Article  PubMed  Google Scholar 

  46. Talwalkar JA, Angulo P, Keach JC, et al (2005) Mycophenolate mofetil for the treatment of primary sclerosing cholangitis. Am J Gastroenterol 100: 308–12

    Article  CAS  PubMed  Google Scholar 

  47. Talwalkar JA, Gossard AA, Keach JC, et al (2007) Tacrolimus for the treatment of primary sclerosing cholangitis. Liver Int 27: 451–3

    Article  CAS  PubMed  Google Scholar 

  48. Tischendorf JJW, Hecker H, Krüger M, et al (2007) Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study. Am J Gastroenterol 102: 107–14

    Article  PubMed  Google Scholar 

  49. Umemura T, Zen Y, Hamano H, et al (2007) Immunoglobin G4-hepatopathy: association of immunoglobulin G4-bearing plasma cells in liver with autoimmune pancreatitis. Hepatology 46: 463–71

    Article  CAS  PubMed  Google Scholar 

  50. Washington K, Clavien PA, Killenberg P (1997) Peribiliary vascular plexus in primary sclerosing cholangitis and primary biliary cirrhosis. Hum Pathol 28: 791–5

    Article  CAS  PubMed  Google Scholar 

  51. Wee A, Ludwig J (1985) Pericholangitis in chronic ulcer-ative colitis: primary sclerosing cholangitis of the small bile ducts? Ann Intern Med 102: 581–7

    CAS  PubMed  Google Scholar 

  52. Weismüller TJ, Wedemeyer J, Kubicka S, et al (2008) The challenges in primary sclerosing cholangitis—aetiopathogen-esis, autoimmunity, management and malignancy. J Hepatol 48: S38–S57

    Google Scholar 

  53. Wiesner RH, Grambsch PM, Dickson ER, et al (1989) Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology 10: 430–6

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair, Department of Medicine II, Klinikum Offenbach, Goethe University Frankfurt/Main, Starkenburgring 66, Offenbach, 63069, Germany

    Henryk Dancygier (Professor of Medicine)

  2. Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA

    Henryk Dancygier (Professor of Medicine)

Authors
  1. Henryk Dancygier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H. (2010). Primary Sclerosing Cholangitis. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_21

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_21

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation